Considerations for Optimal Management of Patients With Pulmonary Arterial Hypertension: A Multi-Stakeholder Roundtable Discussion
BySean M. Studer, MD, MSc,Martha Kingman, FNP-C,DNP,Luis Calo, MD, MMM, FAAFP,H. Eric Cannon, PharmD, FAMCP,Jeffrey D. Dunn, PharmD, MBA,Thomas James III, MD,Sonya J. Lewis, PharmD, MBA,Robert J Stakeholders, including national and regional managed care decision makers and providers, met to discuss the clinical background, health economics, and management strategies for pulmonary arterial hypertension (PAH) at a roundtable meeting on December 10, 2016, in Dallas, Texas.
